Colon Cancer
Research from University Hospital provides new data about colon cancer
Published in Immunotherapy Weekly, May 26th, 2010
Current study results from the report, 'Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer,' have been published. According to recent research published in the journal Chemotherapy, "We gathered data from multiple institutions on the cetuximab regimen of patients with metastatic colorectal cancer. 126 patients from 19 centers were included from July 2006 to July 2007 in this prospective non-controlled study."
"Irinotecan-refractory metastatic colorectal cancer patients with Karnofsky >or=70 received cetuximab 500 mg/m2 every 2 weeks (q2w) in combination with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2010-05-26)
More Articles from Immunotherapy Weekly
- Allergies
Researchers from Post Graduate Institute of Medical Education and Research provide details of new studies and findings in the area of allergies - Nasal Polyps
Reports outline nasal polyps research from University Hospital - Quality of Life
University of Michigan, Center for Managing Chronic Disease describes research in quality of life - Gender and Health
Aalborg Hospital, Department of Occupational Medicine reports research in gender and health - Allergies
New allergies research has been reported by C. Incorvaia et al - Asthma
Researchers from University of Paris report details of new studies and findings in the area of asthma - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
